Further-attenuated measles vaccine: Virus passages affect viral surface protein expression, immunogenicity and histopathology pattern in vivo

Boriskin, 1986, Measles virus persistent infection: modification of the virus nucleocapsid protein, J. gen. Virol., 67, 1979, 10.1099/0022-1317-67-9-1979 Boriskin, 1988, Salt-induced enhancement of measles virus yields in cultured cells, Arch. Virol., 101, 131, 10.1007/BF01314658 Boriskin, 1988, Laboratory markers for overattenuation of mumps vaccine virus, Vaccine, 6, 483, 10.1016/0264-410X(88)90097-7 Calain, 1988, Generation of measles virus defective interfering particles and their presence in a preparation of attenuated live-virus vaccine, J. Virol., 62, 2859, 10.1128/JVI.62.8.2859-2866.1988 Cattaneo, 1988, Biased hypermutation and other genetic changes in defective measles viruses in human brain infections, Cell, 55, 255, 10.1016/0092-8674(88)90048-7 Drillien, 1988, Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein, 85, 1252 Hardwick, 1978, Glycoproteins of measles virus under reducing and non-reducing conditions, J. Virol., 25, 687, 10.1128/JVI.25.2.687-692.1978 Mirchamsy, 1988, Evaluation of live attenuated measles vaccines prepared in human diploid cells for a reimmunization, Epidem. Inf., 101, 437, 10.1017/S095026880005439X Nagieva, 1989, Generation and properties of hybridomas producing monoclonal antibodies to Leningrad-16 measles virus, Probl. Virol. (Russian), 2, 204 Nakhase, 1989, Rubella virus: mechanism of attenuation in the vaccine strain (HPV 77), Virus Res., 13, 231, 10.1016/0168-1702(89)90018-X Norrby, 1975, Difference in the appearance of antibodies against virus envelope components of measles virus after immunization with inactivated and live virus, J. infect. Dis., 132, 262, 10.1093/infdis/132.3.262 Norrby, 1976, Measles vaccination. III.—The occurrence of antibodies against virus envelope components after immunization with inactivated vaccine, Acta Paediatr. Scand., 65, 171, 10.1111/j.1651-2227.1976.tb16532.x Olmsted, 1984, Sindbis virus mutants selected for rapid growth in cell culture display attenuated virulence in animals, Science, 225, 424, 10.1126/science.6204381 Rozenblatt, 1979, Infective substructures of measles virus from acutely and persistently infected cells, J. Virol., 32, 329, 10.1128/JVI.32.1.329-333.1979 Rozina, 1988, Comparative clinico-morphological study of monkey CNS and guinea pig eye teguments infected with different measles virus strains, Acta Virol., 32, 123 Sassani, 1987, Excessive attenuation of measles virus as a possible cause of failure in measles immunization, Ann. Inst. Pasteur/Virol., 138, 491, 10.1016/S0769-2617(87)80038-2 Sato, 1989, Protective role of human antibodies to the fusion protein of measles virus, Microbiol. Immunol., 33, 601, 10.1111/j.1348-0421.1989.tb02010.x Steinhauer, 1987, Rapid evolution of RNA viruses, Ann. Rev. Microbiol., 41, 409, 10.1146/annurev.mi.41.100187.002205 Wegmann, 1986, Comparative study end evaluation of further attenuated, live measles vaccine alone and in combination with mumps and rubella vaccines, Develop. Biol. Stand., 65, 69 Whittle, 1988, Effects of dose and strain of vaccine on success of measles vaccination of infants aged 4–5 months, Lancet, I, 963, 10.1016/S0140-6736(88)91780-1